Samabriva
Private Company
Funding information not available
Overview
Samabriva is a private, pre-revenue biotechnology company founded in 2011, headquartered in Paris and Amiens, France, with a biomanufacturing facility in Liège, Belgium. The company has developed a unique, patented bioproduction platform based on plant hairy root cultures grown in bioreactors, enabling the contained, year-round production of complex biomolecules. Operating primarily as a platform and service provider (CDMO/CFO model), Samabriva targets pharmaceutical and biotech clients seeking to outsource the production of plant-derived active ingredients, recombinant proteins, and virus-like particles (VLPs) with greater supply chain control and a reduced environmental footprint. Recent milestones include opening a new production facility and forming strategic partnerships, such as with Généthon for AAV vector production.
Technology Platform
Proprietary, automated bioproduction platform using plant hairy root cultures grown in bioreactors for the contained, sustainable production of secondary metabolites, recombinant proteins, and VLPs.
Opportunities
Risk Factors
Competitive Landscape
Samabriva competes with established mammalian and microbial CDMOs, as well as other innovative bioproduction platforms using plant cell cultures or whole-plant molecular farming. Its differentiation lies in the specific use of hairy root cultures for their genetic stability and productivity in a fully contained bioreactor system.